EBV Antigen and Cell Cycle Regulation
EBV Antigen and Cell Cycle Regulation
批准号:
7611438
负责人:
ERLE S. ROBERTSON
金额:
$29.41万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-01 至 2013-11-30
关键词:
Adult Hodgkin&aposs LymphomaAffectAmino AcidsAntigensB-Cell LymphomasB-LymphocytesBindingBiochemicalBiologyBurkitt LymphomaCell CycleCell Cycle ProgressionCell Cycle ProteinsCell Cycle RegulationCell LineCell ProliferationCell Proliferation RegulationCell SurvivalCell physiologyCellsComplementComplexCyclin ACyclin D1CyclinsDNA Tumor VirusesDataDeubiquitinationDevelopmentDiseaseE2F transcription factorsEpisomeEpstein-Barr Virus Nuclear AntigensEquilibriumEscherichia coliEventGene ExpressionGenesGenetic TranscriptionGenomeHerpesviridaeHomeostasisHumanHuman Herpesvirus 4ImmuneImmunocompromised HostIn VitroIndividualKnock-outLinkLymphoproliferative DisordersMaintenanceMalignant NeoplasmsMapsMediatingModelingModificationMolecularMolecular BiologyMolecular GeneticsMonitorMutationNME1 geneNasopharynx CarcinomaNuclear AntigensOncogene ProteinsPhosphotransferasesPost-Translational Protein ProcessingRecombinantsRegulationRepressionRetinoblastoma ProteinRoleSignal TransductionSiteSite-Directed MutagenesisT-Cell LymphomaTherapeutic AgentsTranscription Repressor/CorepressorTranscriptional RegulationTranslationsTransplant RecipientsTumor Suppressor ProteinsViralViral AntigensVirusVirus Latencyc-myc Genescell growth regulationcell transformationcellular targetingchromatin remodelinggammaherpesvirusgenetic analysisinfected B cellinhibitor/antagonistinsightinterestlymphoblastoid cell linemutantnovelprogramspublic health relevancerecombinant virusresearch studyrole modeltumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The ubiquitous human Epstein-Barr virus (EBV) has been shown to be linked to a wide range of human cancers which include Burkitt's lymphoma, nasopharyngeal carcinoma, Hodgkin's lymphoma, adult T-cell lymphomas and lymphoproliferative diseases in immunocompromised patients. In vitro, EBV can efficiently transform human primary B-cells in vitro resulting in continual proliferation of the infected primary B-cells into transformed lymphoblastoid cell lines (LCLs). The nascently transformed B-lymphocytes by EBV are strictly latent in that a select set of genes are expressed, one of which is Epstein-Barr nuclear antigen (EBNA) 3C. EBNA3C has been shown to be essential for B cell transformation in vitro by genetic analysis of the virus. Over the last decade the functions associated with EBNA3C has linked this essential molecule to regulation of viral and cellular transcription through interaction with the transcription repressor CSL, Nm23-H1, the tumor suppressor molecule Rb and other cell cycle regulatory factors which include Cyclin A and Cyclin D1. This proposal will investigate the interactions of the essential EBV nuclear antigen 3C and the cellular factors E2F and c-Myc involved in regulation of cell proliferation, cell cycle, transcription, and signaling involved in maintenance of cellular homeostasis. The specific amino acids of these cellular targets c-Myc and E2F interacting with 3C will be explored and the functional relationships examined in terms of B cell transformation and immortalization. The post-translational modifications of c-Myc and E2F important for activation of their regulatory functions will also be fully investigated. Simultaneously, we will generate site specific recombinant EBNA3C molecules that are knocked out for the specific interactions within the EBV genome to determine their role in primary B cell transformation. PUBLIC HEALTH RELEVANCE: The ubiquitous gammaherpesvirus Epstein Barr virus is associated with a range of human cancers. At least 6 latent genes have been shown to be critical for cell transformation in vitro. Some of these antigens associate directly with cell cycle regulatory proteins and are also linked to the specific regulation of cellular events which include regulation of transcription, chromatin remodeling, cell proliferation and cell cycle regulation. This proposal will explore the role of one of the essential nuclear antigens EBNA3C in determining a more comprehensive model for the related functions of EBNA3C in regulation of the major cellular oncoproteins E2F and c-Myc through post-translation modification and cell cycle regulation leading to transformation of human B cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Botswana-UPenn: Research Consortium of HPV-Related Cervical Cancer in HIV Patient
-
批准号:10834480
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2023
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Project 1: KSHV reprograms replication and metabolic activities in hypoxia
-
批准号:10714173
-
项目类别:
-
资助金额:$46.85万
-
财政年份:2023
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Transcription and Replication of Oncogenic Viruses in Hypoxia
-
批准号:10714172
-
项目类别:
-
资助金额:$269.7万
-
财政年份:2023
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Virus, Vector and Cell Culture Core
-
批准号:10714178
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2023
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Administrative Core
-
批准号:10714177
-
项目类别:
-
资助金额:$11.33万
-
财政年份:2023
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia
-
批准号:10714174
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2023
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Next Generation Sequencing Core
-
批准号:10714179
-
项目类别:
-
资助金额:$45.67万
-
财政年份:2023
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Tumor suppressor reprogramming by EBV through post-translational modification
-
批准号:10402055
-
项目类别:
-
资助金额:$53.94万
-
财政年份:2022
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Tumor suppressor reprogramming by EBV through post-translational modification
-
批准号:10684650
-
项目类别:
-
资助金额:$53.33万
-
财政年份:2022
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Epigenetic Regulation of KSHV Genome Replication
-
批准号:10457380
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2019
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Epigenetic Regulation of KSHV Genome Replication
-
批准号:9978759
-
项目类别:
-
资助金额:$49.57万
-
财政年份:2019
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Epigenetic Regulation of KSHV Genome Replication
-
批准号:10669729
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2019
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Epigenetic Regulation of KSHV Genome Replication
-
批准号:10208828
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2019
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Natural History & Pathogenesis of HPV in HIV infected women with cervical cancer
-
批准号:8936659
-
项目类别:
-
资助金额:$10.55万
-
财政年份:2014
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients
-
批准号:8794812
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2014
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients
-
批准号:9770545
-
项目类别:
-
资助金额:$95.29万
-
财政年份:2014
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients
-
批准号:9128422
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2014
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients
-
批准号:8927590
-
项目类别:
-
资助金额:$74.78万
-
财政年份:2014
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Early Events in KSVH Infection of Primary B-cells
-
批准号:8540468
-
项目类别:
-
资助金额:$186.18万
-
财政年份:2013
-
负责人:ERLE S. ROBERTSON
-
依托单位:
Genome Persistence of KSHV
-
批准号:8467401
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2013
-
负责人:ERLE S. ROBERTSON
-
依托单位:
海外基金